„Ozempic natural”, descoperit cu ajutorul inteligenței artificiale. Cercetătorii spun că ar putea reduce apetitul fără efectele adverse cunoscute

Researchers at Stanford Medicine have identified a natural molecule, BRP, that may lead to new obesity treatments. This peptide, discovered using AI, shows effects similar to Ozempic in reducing appetite and weight without significant side effects. BRP primarily targets the hypothalamus, potentially explaining the absence of common digestive issues seen with current medications. Animal studies indicate that a single injection can reduce food intake by up to 50%, and treated obese mice lost weight mainly through fat reduction. Clinical trials are planned to assess BRP's safety and efficacy in humans, as obesity remains a global health concern.